Substance / Medication

Rimantadine

Overview

Active Ingredient
rimantadine
RxNorm CUI
9386

Indications & Related Conditions

Conditions associated via SNOMED clinical relationships

Administration & Protocol

Dosing, route, and treatment protocol

Administration details including route, dosing schedules, preparation instructions, and contraindications are pending physician authorship.

Monitoring & Follow-Up

Biomarkers relevant to this intervention via related conditions

No monitoring biomarkers have been mapped yet. Biomarker-intervention linkages are derived through related conditions and will expand as the knowledge graph grows.

Research Evidence

Published studies and systematic reviews

Sort:
Amantadine and rimantadine for influenza A in children and the elderly.
Alves Galvão Márcia G, Rocha Crispino Santos Marilene Augusta, Alves da Cunha Antonio J L · Cochrane Database Syst Rev · 2014
PMID: 25415374Meta-AnalysisFull text (PMC)
Amantadine and rimantadine for influenza A in children and the elderly.
Alves Galvão Márcia G, Rocha Crispino Santos Marilene Augusta, Alves da Cunha Antonio Jl · Cochrane Database Syst Rev · 2012
PMID: 22258950Meta-Analysis
Amantadine and rimantadine for influenza A in children and the elderly.
Alves Galvão M G, Rocha Crispino Santos M A, Alves da Cunha A J L · Cochrane Database Syst Rev · 2008
PMID: 18254006Meta-Analysis
Amantadine and rimantadine for influenza A in adults.
Jefferson T, Demicheli V, Di Pietrantonj C et al. · Cochrane Database Syst Rev · 2006
PMID: 16625539Meta-AnalysisFull text (PMC)
Amantadine and rimantadine for preventing and treating influenza A in adults.
Jefferson T, Deeks J J, Demicheli V et al. · Cochrane Database Syst Rev · 2004
PMID: 15266442Meta-Analysis
A case for rimantadine to be marketed in Canada for prophylaxis of influenza A virus infection.
Marra Fawziah, Marra Carlo A, Stiver H Grant · Can Respir J · 2003
PMID: 14571290Meta-Analysis
Amantadine and rimantadine for preventing and treating influenza A in adults.
Jefferson T O, Demicheli V, Deeks J J et al. · Cochrane Database Syst Rev · 2002
PMID: 12137620Meta-Analysis
Amantadine and rimantadine for preventing and treating influenza A in adults.
Jefferson T O, Demicheli V, Deeks J J et al. · Cochrane Database Syst Rev · 2001
PMID: 11405978Meta-Analysis
Amantadine and rimantadine for preventing and treating influenza A in adults.
Jefferson T O, Demicheli V, Deeks J J et al. · Cochrane Database Syst Rev · 2000
PMID: 10796612Meta-Analysis
Absence of pharmacokinetic interaction between intravenous peramivir and oral oseltamivir or rimantadine in humans.
Atiee George, Lasseter Kenneth, Baughman Sharon et al. · J Clin Pharmacol · 2012
PMID: 21960669RCT

Research data from MEDLINE/PubMed

Benefits & Expected Outcomes

Benefits, expected outcomes, efficacy data, and NNT (Number Needed to Treat) are pending physician authorship and evidence review.

Risks & Side Effects

Risk profile, common and serious adverse effects, contraindications, and drug interactions are pending physician authorship.

Related Symptoms

Symptoms associated with conditions this intervention addresses

No related symptoms have been mapped yet. Symptom linkages are derived through associated conditions.

Alternatives & Comparisons

Alternative treatments, comparison data, and clinical decision support are pending physician authorship.

Medical Disclaimer

This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult with a qualified healthcare provider regarding any medical condition or treatment plan.

Do not start, stop, or change any treatment without consulting your healthcare provider.

Quick Facts

Type
Substance / Medication
Fully Specified Name
Rimantadine (substance)
SNOMED CT
372532009
UMLS CUI
C0035629
RxNorm CUI
9386

Clinical Data

This intervention maps to 1 entities in the Healos knowledge graph.

1
Conditions
0
Biomarkers
0
Specialists
0
Symptoms

Data is sourced from SNOMED CT, UMLS, and the Healos clinical knowledge graph. Content sections marked as pending require physician authorship. Consult a healthcare provider before starting any treatment.